Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)

NCT02409680 is registered in ClinicalTrials.gov with NICHD Global Network for Women's and Children's Health as lead sponsor.

NCT NCT02409680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02409680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)
Lead sponsor
NICHD Global Network for Women's and Children's Health
Phase
Not applicable
Overall status
Completed
Start date
March 23, 2016
Completion date
April 11, 2019
Enrollment
11,976 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

premature birth